{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2193525"],"location":["China"],"study_start_month":["3"],"keyword":["Previously treated metastatic colorectal cancer","CM4307"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer","description":"The investigators do the clinical trial (patients with metastatic colorectal cancer treated with donafenib after failure of standard therapy) to assess safety and efficacy of donafenib in patients with metastatic colorectal cancer, progressing after all approved standard therapies.","dates":{"creation":"2014-03-15"},"accession":"2193525","cross_references":{"ClinicalTrials___gov":["NCT02489916"]}}